Acquirer
Allergan
Allergan appears as the named buyer in 14 recorded transactions between 2014 and 2018, most often in healthcare & life sciences. 4 of those were bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Allergan has bought
Every recorded transaction where Allergan is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Bonti | Healthcare & Life Sciences | — | 2018-09-14 | $195m |
| Chase Pharmaceuticals Corporation | Healthcare & Life Sciences | Edmond de Rothschild Private Equity PE | 2016-11-22 | $125m |
| Akarna Therapeutics Ltd. | Healthcare & Life Sciences | — | 2016-09-20 | $50m |
| Vitae Pharmaceuticals | Healthcare & Life Sciences | — | 2016-09-14 | $639m |
| RetroSense Therapeutics | Healthcare & Life Sciences | — | 2016-09-06 | $60m |
| ForSight VISION5 | Healthcare & Life Sciences | ForSight Labs LLC | 2016-08-11 | $95m |
| Topokine Therapeutics | Healthcare & Life Sciences | Schooner Capital PE | 2016-04-21 | $85m |
| Anterios | Healthcare & Life Sciences | — | 2016-01-07 | $90m |
| AqueSys | Healthcare & Life Sciences | The Carlyle Group PE | 2015-10-19 | $300m |
| Naurex | Healthcare & Life Sciences | Adams Street Partners PE | 2015-08-31 | $560m |
| Oculeve | Healthcare & Life Sciences | — | 2015-08-10 | $125m |
| Auden Mckenzie Holdings Ltd. | Healthcare & Life Sciences | — | 2015-01-26 | $471m |
| Motus Therapeutics | Healthcare & Life Sciences | Rhythm Pharmaceuticals | 2014-10-22 | $40m |
| Durata Therapeutics | Healthcare & Life Sciences | — | 2014-10-06 | $675m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.